Ronny Isaac Drapkin MD PhD

Anatomic Pathology, Clinical Pathology

Professor (tenured), Director - Penn Ovarian Cancer Research Center, Director - Gynecologic Cancer Research, Basser Center for BRCA, University of Pennsylvania

Join to view full profile

1 Jimmy Fund Way# Dana-FarBoston, MA 02115
Phone+1 617-632-4380
Fax+1 617-632-4381

Dr. Drapkin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Drapkin's full profile Already have an account?

Summary

Dr. Ronny Drapkin is a physician-scientist in Philadelphia, PA affiliated with the University of Pennsylvania Perelman School of Medicine. He received his MD and PhD degrees from Rutgers Robert Wood Johnson Medical School followed by a residency in Pathology at the Brigham & Women's Hospital in Boston. He completed a postdoctoral fellowship at the Dana-Farber Cancer Institute before joining the faculty at Harvard Medical School and the DFCI. He was recruited to Penn in 2015 where he is the Franklin Payne Professor of Pathology in Gynecologic Oncology. He also speaks multiple languages, including Spanish. He has more than 250 publications and over 33,000 citations.

Education & Training

Dana-Farber Cancer InstitutePost-Doctoral Fellowship, 2001 - 2006
Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2001
Rutgers Robert Wood Johnson Medical SchoolClass of 1998
Rutgers Graduate School of Biomedical SciencesPhD, Biochemistry, 1992 - 1996
Brandeis UniversityBA, 1986 - 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2001 - 2016

Awards, Honors, & Recognition

Innovation Award Society of Gynecologic Oncology (SGO), 2024
Inducted Member American Association of Physicians (AAP), 2023
Rosalind Franklin Prize for Excellence in Ovarian Cancer Research Ovarian Cancer Research Fund Alliance, 2017

Publications & Presentations

PubMed

Ciliated Cells Drive Critical STING-Mediated Tumor Suppression in the Fallopian Tube Epithelium.
Jose A Colina, Maria Sol Recouvreux, Alexander M Sobeck, Benjamin K Johnson, Yinzhi Lin
Cancer Research. 2026-06-15
Rethinking ovarian cancer III: the past decade and future directions.
Frances R Balkwill, Céline M Laumont, Nikki Burdett, Olivia Le Saux, Dale W Garsed
Nature Reviews. Cancer. 2026-06-01
Spatial integration of protein and chromosomal states reveals early copy number changes and genotype-associated immune neighborhoods in serous ovarian cancer evolution.
Tanjina Kader, Yu-An Chen, Clemens B Hug, Jia-Ren Lin, Jeremy L Muhlich
Cancer Discovery. 2026-04-18

Journal Articles

Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian Tumors
Leona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology

Press Mentions

Pitt Study Makes New Insights into the Origins of Ovarian CancerMarch 14th, 2025
Six Warning Signs of Ovarian CancerMay 8th, 2023
Five Bizarre Warning Signs of Ovarian Cancer RevealedMarch 7th, 2023

Grant Support

SPORE in Ovarian CancerJOHNS HOPKINS UNIVERSITY2018–2029
PROTEOMIC GENETIC AND LONGITUDINAL PATHS TO OVARIAN CANCER BIOMARKER DISCOVERYNATIONAL CANCER INSTITUTE2014–2020
Cyclin E1 as a Therapeutic Target in Women with High-Grade Serous Ovarian Cancer and Primary Treatment FailurePMCC/Dept. of the Army – USAMRAA2015–2018
Cyclin E: Targeting Cell Cycle Dependencies in Ovarian CancerAdelson Medical Research Foundation (AMRF)2014–2017
ELAFIN AS A BIOMARKER IN SEROUS OVARIAN CANCERS AND BASAL-LIKE BREAST TUMORSNational Cancer Institute (NCI)2013–2015